Search
Puma Biotechnology Inc
PBYIAdd to Watchlist
7.560USD
+0.330+4.56%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
384.65MMarket Cap
15.48P/E TTM
Financial Health
Currency: USD Updated: 2026-06-18 The current financial score of Puma Biotechnology Inc is 7.49, ranking 113 out of 157 in the Pharmaceuticals industry. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 44.81M, representing a year-over-year decrease of 2.59%, while its net profit experienced a year-over-year decrease of 226.19%.
Financials
8.11
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Quality of Earnings
3.35
Total revenue
Operating profit
Total assets
SG&A
Relevant data have not been disclosed by the company yet.
Operational Efficiency
10.00
Cash flow from operating activities
Income after tax
Relevant data have not been disclosed by the company yet.
Growth Potential
8.55
Cash flow from operating activities
Total revenue
Relevant data have not been disclosed by the company yet.
Shareholder Returns
7.43
Free cash flow
Relevant data have not been disclosed by the company yet.
